Jeevan Umang solves one problem elegantly: guaranteed income for life. Once you finish paying premiums in your 40s or 50s, the policy converts into a perpetual ₹X/year cheque that never stops — not even at 80 or 100. The death benefit (Sum Assured + all vested bonuses) is preserved separately, so the income doesn't cannibalize what your nominee receives. The XIRR logic is unusual: the longer you live, the better the return, which makes this plan a natural hedge against longevity risk. The flip side is that the premium outlay is high relative to the income, and buyers who don't live past their late 60s see poor outcomes. If longevity runs in your family and you want an income floor that can't be outlived, Jeevan Umang is one of the few products that does this within a traditional insurance wrapper.

• The 8% annual income is guaranteed in the policy document — it is not subject to bonus declarations. The only variable is the terminal death/maturity benefit, which depends on vested reversionary bonuses.
• XIRR is age-sensitive. At a 70-year horizon it's modest (~5.5%); at 90 it's strong (~7%). Drag the calculator's horizon slider to understand your own scenario.
• This is not a high-yield product. It's a longevity-insurance product. The comparison isn't 'vs FD' — it's 'vs the risk of running out of money at 85'.
• ₹10L SA with PPT 20 costs roughly ₹44,000/yr and pays ₹80,000/yr from age 50 onwards. Breakeven (income = premiums paid) is typically around age 57–60.
• Death benefit at any point = SA + all vested SRBs to date of death. The survival income does NOT reduce the nominee's proceeds.
• FAB (Final Additional Bonus) only accrues at age 100 or death after age 100. It's a large-but-distant number — do not anchor your decision to it.

Asymmetrica isn't an insurance advisor. The opinions above are editorial; the numbers in the calculator are computed from the plan's own brochure. Read both, then decide.